I doubt its happening this year @JFlo as I said "down the track." And whether Imugene is in control at that stage is yet to be seen. Seattle Genetics transformed into Seagen before reaching this level of success, as outlined in my post. What, when and if IMU morphs into another being, partners up with someone or fly's solo is yet to be seen. I'm not ruling out that level of value for the products created by Fong, Wiedermann, Priceman and Kaumaya, but who owns them at the end of the day is yet to be determined. Realistically I do hope it's Imugene in partnership with a supportive Big Pharma backer. But as we know it's getting to the pointy end for some of the candidates in the Imugene stable, and their Chair Paul Hopper has never expressed an interest in commercialising or indeed marketing his products. And from a business perspective that is probably better left to people who actually do that.
Though I for one would love to see Professor Fong's Vaxinia become human therapy for all those charged with the pain and suffering associated with a solid tumour cancer diagnosis. Oh and what about realising the true potential of PD1 Vaxx and Her Vaxx...don't get me started again...
Thanks @Taureanbull I do believe PD1 Vaxx like Her Vaxx, now being trialled at their optimal dosage rates, shall open the door for both in house and external combinations with an array of monoclonal antibodies and OV's such as CF33, once their ongoing trial results come to fruition..Their safety, low toxicity, relatively low costs, ease of administration and ultimate efficacy (i.e., to be determined) are sure to appeal to multiple treatment providers....
@WhatAGas thanks for your comment...My take on it is our market is asleep at the wheel...A Nasdaq listing as I have been suggesting for years is a potential game breaker in terms of market movement, brand awareness and long term growth...
@Footmax thanks as always for your comments...I must say I am proud of this post...I'm keeping this one for the book to look back on in the fullness of time... In response to your suggestion yes I believe the media should be all over Professor Fong's forthcoming visit...A Current Affair, Nine News, Seven News, ABC News and The 7.30 Report viewers would all benefit, as US TV has from hearing of Professor Fong's medical breakthrough with the Vaxinia Virus..
Let's hope management has given their communications team a real shot in the arm and told them to lift their game and ensure these TV programs are kept abreast of Professor Fong's every move whilst out here..
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
IMU
imugene limited
Add to My Watchlist
7.69%
!
1.2¢

Why IMU is a multi multi bagger, page-11738
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $140.7K | 11.61M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
50 | 9000852 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 6923007 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
49 | 8984186 | 0.012 |
49 | 12950641 | 0.011 |
67 | 25218374 | 0.010 |
17 | 3643042 | 0.009 |
9 | 2663499 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 6923007 | 25 |
0.014 | 7952040 | 31 |
0.015 | 8596367 | 30 |
0.016 | 7393011 | 30 |
0.017 | 12265156 | 16 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |